These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8539767

  • 41. Vaccines in the prevention of viral pneumonia.
    Betts RF.
    Semin Respir Infect; 1995 Dec; 10(4):282-7. PubMed ID: 8668856
    [Abstract] [Full Text] [Related]

  • 42. Influenza vaccine 2007-2008.
    Med Lett Drugs Ther; 2007 Oct 08; 49(1271):81-3. PubMed ID: 17912142
    [No Abstract] [Full Text] [Related]

  • 43. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
    Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM, American Heart Association, American College of Cardiology, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Critical Care Nurses, American Association of Heart Failure Nurses, American Diabetes Association, Association of Black Cardiologists, Inc, Heart Failure Society of America, Preventive Cardiovascular Nurses Association, American Academy of Nurse Practitioners, Centers for Disease Control and Prevention and the Advisory Committee on Immunization.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1498-502. PubMed ID: 17010820
    [Abstract] [Full Text] [Related]

  • 44. Influenza vaccination of children and infection rates in the community.
    Small PA, Morris JG.
    JAMA; 2010 Jun 16; 303(23):2355-6; author reply 2356. PubMed ID: 20551404
    [No Abstract] [Full Text] [Related]

  • 45. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G, Greenbaum E, Zakay-Rones Z.
    Isr Med Assoc J; 2006 Mar 16; 8(3):155-8. PubMed ID: 16599048
    [Abstract] [Full Text] [Related]

  • 46. Reduced-dose influenza vaccine.
    Wyatt KN, Ryan GJ, Sheerin KA.
    Ann Pharmacother; 2006 Sep 16; 40(9):1635-9. PubMed ID: 16835314
    [Abstract] [Full Text] [Related]

  • 47. ACIP releases recommendations for use of live, attenuated influenza vaccine.
    Ressel GW, ACIP of the Centers for Disease Control and Prevention.
    Am Fam Physician; 2003 Dec 01; 68(11):2275-6. PubMed ID: 14677671
    [No Abstract] [Full Text] [Related]

  • 48. [Epidemiological effectiveness of live influenza vaccines].
    Serebriakov LV, Rzhanov VE, Semeniuk VG, Stepanchuk VA.
    Voen Med Zh; 1974 Oct 01; (10):54-5. PubMed ID: 4439678
    [No Abstract] [Full Text] [Related]

  • 49. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS, Sorokin EM, Zoschenkova NY, Zacharova NG, Naichin AN.
    J Biotechnol; 1996 Jan 26; 44(1-3):21-8. PubMed ID: 8717382
    [Abstract] [Full Text] [Related]

  • 50. The imperative of influenza vaccines for elderly individuals-an evolving story.
    Poland GA, Mulligan MJ.
    J Infect Dis; 2009 Jul 15; 200(2):161-3. PubMed ID: 19508160
    [No Abstract] [Full Text] [Related]

  • 51. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Dec 11; 58(48):1351-6. PubMed ID: 20010511
    [Abstract] [Full Text] [Related]

  • 52. [Influenza vaccination in children: Inactivated vaccines or live attenuated vaccines?].
    Brouard J, Tran L, Flammang A, Dupont C, Vabret A.
    Arch Pediatr; 2017 Mar 11; 24(3):211-214. PubMed ID: 28131556
    [No Abstract] [Full Text] [Related]

  • 53. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children.
    Ozgur SK, Beyazova U, Kemaloglu YK, Maral I, Sahin F, Camurdan AD, Kizil Y, Dinc E, Tuzun H.
    Pediatr Infect Dis J; 2006 May 11; 25(5):401-4. PubMed ID: 16645502
    [Abstract] [Full Text] [Related]

  • 54. Avian influenza vaccines and therapies for poultry.
    Swayne DE.
    Comp Immunol Microbiol Infect Dis; 2009 Jul 11; 32(4):351-63. PubMed ID: 18442853
    [Abstract] [Full Text] [Related]

  • 55. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Arnoux S, Weinberger C, Gessner BD.
    Vaccine; 2007 Nov 07; 25(45):7720-31. PubMed ID: 17920168
    [Abstract] [Full Text] [Related]

  • 56. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E, Ioniţă E, Botez D, Matepciuc M, Tabra ME, Tecu C, Alexandrescu V, Munţiu A.
    Bacteriol Virusol Parazitol Epidemiol; 1997 Nov 07; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract] [Full Text] [Related]

  • 57. Influenza prevention, 1989-1990.
    Med Lett Drugs Ther; 1989 Oct 20; 31(803):95-6. PubMed ID: 2796844
    [No Abstract] [Full Text] [Related]

  • 58. [Possibility of using killed influenza vaccine as a means of emergency influenza prevention].
    Agafonov VI, Perepelkin VS, Siutkin PP.
    Voen Med Zh; 1977 Jan 20; (1):51-4. PubMed ID: 841895
    [No Abstract] [Full Text] [Related]

  • 59. Cold-adapted, live attenuated intranasal influenza virus vaccine.
    Zangwill KM.
    Pediatr Infect Dis J; 2003 Mar 20; 22(3):273-4. PubMed ID: 12634591
    [No Abstract] [Full Text] [Related]

  • 60. New vaccine approaches for seasonal and pandemic influenza.
    Palache B.
    Vaccine; 2008 Nov 18; 26(49):6232-6. PubMed ID: 18674583
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.